Miiskin
Miiskin is a Denmark-headquartered teledermatology platform connecting patients with independent, board-certified dermatologists across the US, Mexico, and Denmark via asynchronous photo-based consultations, charging $59 per new visit with no subscriptions.
- Company typePrivate
- Founded2022
- HeadquartersCopenhagen, Denmark
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What Miiskin does
Miiskin Group ApS is a Denmark-headquartered digital health company operating a direct-to-consumer teledermatology platform that connects patients with independent, board-certified dermatologists for asynchronous, photo-based consultations. Founded in 2022, Miiskin serves patients across all 50 US states, Mexico, and Denmark via its website and native iOS/Android applications. The core platform enables patients to self-select a dermatologist, submit high-resolution photos and clinical intake data, and receive a diagnosis, treatment plan, and prescription within 24–48 hours, compared to a reported industry-average wait of over 30 days for in-person appointments. Pricing is transparent and pay-per-visit: $55–$69 for new consultations (typically $59) and $30–$39 for prescription renewals, with no mandatory subscriptions.
The platform's technology stack includes HIPAA-compliant secure photo storage with IBM as cloud partner, GDPR and CCPA compliance, and LegitScript certification. Miiskin earns revenue through consultation fees, transaction-based compounded prescription fulfillment via Foothills Pharmacy ($48.99–$68.99 per formula), and FDA-approved generic bimatoprost fulfillment. It also operates Miiskin PRO, a provider-facing SaaS offering for dermatology practices, primary care clinics, hospitals, and cancer centers. The company has accumulated 50,000+ consultations and 1,500+ user reviews, and has secured non-dilutive grants from the Innobooster program and the Danish Innovation Fund ($200,000) to develop AI-powered skin disease triage and generative AI workflow automation. Dermatologists on the platform are independent contractors, not Miiskin employees, and patients retain freedom to fill prescriptions at any pharmacy. Stated long-term ambition is to reach 100 million people by 2040.
Miiskin firmographics
Firmographics- Name
- Miiskin
- Legal name
- Miiskin Group ApS
- Website
- https://miiskin.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Miiskin is a Denmark-headquartered teledermatology platform connecting patients with independent, board-certified dermatologists across the US, Mexico, and Denmark via asynchronous photo-based consultations, charging $59 per new visit with no subscriptions.
- Ownership category
- akta.pro rank
Miiskin industry classification
Industry- Product category
- Teledermatology Services
- NAICS
- Offices of Physicians (62111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Dermatology Telemedicine Platforms (HLALAGAA)
- akta.pro secondary industries
- Dermatology & Acne Prescribing + Pharmacy Delivery Platforms (HLALAIAK), General & Medical Dermatology (HLAKACAA), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
Keywords
Where Miiskin is headquartered
LocationHeadquarters
- HQ city
- Copenhagen
- HQ country
- Denmark
- HQ region
- Europe
Offices3 records
Markets served
Miiskin business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Consultation Fees: Patients pay per consultation for new visits and prescription renewals. New patient consultations range from $55-$69 (typically $59), while prescription renewals cost $30-$39. This is a pay-per-visit model with no mandatory subscriptions, providing transparent upfront pricing.
- Compounded Prescription Fulfillment: Revenue from customized prescription formulas ordered through partner pharmacy Foothills. Skincare formulas cost $48.99-$58.99, while hair-growth topical formulas cost $68.99. Patients can also use their preferred pharmacy for FDA-approved medications.
- Bimatoprost/Latisse Prescription: FDA-approved generic bimatoprost available through partner Foothills Pharmacy for $78.99, with consultations at $59 for new visits and $39 for follow-ups specifically for Latisse prescriptions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | New Patient Consultation |
| One time/ perpetual license | Pay-as-you-go | Prescription Renewal Consultation |
| Unit Pricing | Pay-as-you-go | Custom Skincare Formula (Foothills) |
| Unit Pricing | Pay-as-you-go | Hair Growth Formula (Foothills) |
| One time/ perpetual license | Pay-as-you-go | Mexico Consultation |
| One time/ perpetual license | Pay-as-you-go | Latisse/Bimatoprost Consultation Package |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels8 records
Miiskin product offering
Product offeringCore offering
Miiskin operates a HIPAA-compliant asynchronous teledermatology platform that connects patients in the United States (all 50 states), Mexico, and Denmark with independent, board-certified dermatologists who review submitted photos, medical history, and clinical questionnaires to deliver diagnoses, personalized treatment plans, and prescriptions within 24–48 hours. Pricing is transparent and pay-per-visit (typically $59 for new consultations, $39 for prescription renewals), with optional compounded medications fulfilled through partner Foothills Pharmacy. The platform also offers Miiskin PRO, a separate provider-facing software for clinical decision support at dermatology practices, primary care clinics, hospitals, and cancer centers.
Product overview
Miiskin operates a dual-sided digital health platform consisting of the Miiskin Teledermatology Platform (core product) and Miiskin PRO (provider-facing software). The platform connects patients with independent, board-certified dermatologists across all 50 U.S. states for asynchronous photo-based consultations, while the Miiskin App enables self-examination and skin tracking. A separate Mexico platform serves the Mexican market. The company also offers compounded medication services through Foothills Pharmacy and pediatric dermatology services. Miiskin received Danish Innovation Fund and Innobooster grants to develop AI-powered features including generative AI for workflow automation and skin disease triage.
Differentiator
Problem solved
Functional benefit
Products and services
- Online Dermatology Consultations Asynchronous photo-based teledermatology service for patients in the United States, Mexico, and Denmark. Patients submit photos, medical history, and clinical questionnaires through the website or mobile app; a board-certified dermatologist reviews and delivers a diagnosis, personalized treatment plan, and (if medically appropriate) a prescription within 24–48 hours. New consultations cost $55–$69 (typically $59), prescription renewals cost $30–$39 (typically $39), with Mexican consultations priced at 499 pesos. Covers acne, anti-aging, hair loss, rosacea, eczema, hyperpigmentation, melasma, psoriasis, Latisse/bimatoprost prescriptions, and 20+ other conditions.
- Miiskin PRO Provider-facing clinical decision-support software for dermatology practices, primary care clinics, hospitals, and cancer centers. Enables healthcare organizations to offer asynchronous photo-based consultations with their existing patients, including patient image submission and information review workflows. Supports AI-powered skin disease triage and treatment recommendation workflows enhanced through Innobooster Grant funding.
- Miiskin App Native mobile application for iOS and Android enabling users to self-examine skin and moles by uploading images, track skin conditions over time (including facial photos for 36 months of inactivity retention), and share medical information with their chosen dermatologists. Available on the Apple App Store and Google Play Store.
- Miiskin Mexico Platform Separate Spanish-language teledermatology platform serving Mexican patients with dermatologists certified by the Consejo Mexicano de Dermatología. Consultations priced at 499 pesos with 1–3 business day response times. Follow-up questions included for 3 days, then 299 pesos for additional questions. Service is available throughout Mexico including CDMX and the interior republic.
- Compounded Medications via Foothills Pharmacy Personalized compounded prescription fulfillment service delivered through partner pharmacy Foothills. Custom skincare formulas cost $48.99–$58.99; specialized topical hair-growth formulas cost $68.99 with free medication shipping. Compounded formulas may include tretinoin, hydroquinone, minoxidil, finasteride, dutasteride, azelaic acid, and other active ingredients as prescribed by Miiskin-affiliated dermatologists. Alternative to FDA-approved medications, which patients may fill at any pharmacy of their choice.
Quantifiable outcome
- Reduced dermatology assessment wait times from over 30 days to 24-48 hours
- +3 more outcomes
Companies that use Miiskin
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles2 records
Miiskin technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature6 records
Miiskin partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Foothills Professional PharmacycorePartner pharmacy for compounded prescription formulas. Patients can select Foothills within the Miiskin platform to order personalized skincare formulas ($48.99-$68.99) with free medication shipping. Provides alternative to FDA-approved medications. Dermatologists can prescribe custom formulas including tretinoin, hydroquinone, minoxidil, and other active ingredients.
- IBM (Cloud Data Storage)coreIBM serves as cloud data storage partner for patient photographs. Photos of face and skin taken for skin monitoring or telehealth consultations are stored with IBM, which complies with HIPAA and GDPR laws controlling use and storage of facial data. Miiskin has contractual agreement with IBM to verify compliance.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Miiskin competitors and assessment
Company assessmentBroad incumbents
- Ro: Multi-specialty telehealth platform with a dermatology/skincare offering (Ro Derm) and integrated pharmacy; competes with Miiskin on consultation-based prescription skincare at a national scale.
- Teladoc Health: Largest US telehealth incumbent with dermatology included in its multi-specialty virtual care offering; not specialized in dermatology but competes for the same virtual-consultation demand.
- Doctor On Demand: General telehealth provider with dermatology visits included; competes with Miiskin on the virtual dermatology visit purchase decision, especially for insured patients.
- Hims & Hers Health: Large telehealth incumbent with a dedicated skin-care vertical (Hers) covering acne, anti-aging and hair loss; broader category reach and far larger marketing budget make it a dominant competitive reference point.
Direct peers
- Curology: Direct-to-consumer online dermatology service offering personalized prescription skincare for acne, anti-aging and hyperpigmentation — directly overlaps Miiskin's core acne, anti-aging and hyperpigmentation use cases and pay-per-visit model.
- Skin + Me: Online dermatologist-led service providing personalized daily-use prescription skincare; closely matches Miiskin's photo-based intake, dermatologist review and custom-formula dispense flow.
- First Derm: Asynchronous online dermatology service providing photo-based dermatologist reviews for skin conditions; direct alternative to Miiskin with similar photo-first consultation workflow.
- DirectDerm: US-focused online dermatology practice offering photo-based consultations with board-certified dermatologists — near-identical service model to Miiskin's patient platform.
- Apostrophe: Online dermatology platform connecting patients with board-certified dermatologists for customized prescription skincare; competes head-to-head with Miiskin on acne, hyperpigmentation and anti-aging compounded formulas.
- Dermatica: UK-based online dermatology service offering customized prescription skincare formulations via subscription — comparable async photo-based model and compounding-fulfillment approach to Miiskin.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Miiskin social profiles
Digital presenceMiiskin compliance and trust
Trust signalCompliance4 records
Miiskin financial estimates
Financial estimateRevenue estimate
Valuation estimate
Miiskin leadership team
Management profileNumber of profiles
Profiles2 records
Miiskin funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Miiskin M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Miiskin
What does Miiskin do?
Miiskin operates a HIPAA-compliant asynchronous teledermatology platform that connects patients in the United States (all 50 states), Mexico, and Denmark with independent, board-certified dermatologists who review submitted photos, medical history, and clinical questionnaires to deliver diagnoses, personalized treatment plans, and prescriptions within 24–48 hours. Pricing is transparent and pay-per-visit (typically $59 for new consultations, $39 for prescription renewals), with optional compounded medications fulfilled through partner Foothills Pharmacy. The platform also offers Miiskin PRO, a separate provider-facing software for clinical decision support at dermatology practices, primary care clinics, hospitals, and cancer centers.
Is Miiskin a public or private company?
Miiskin is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Miiskin founded?
Miiskin was founded in 2022. It employs 1 to 10 people.
Where is Miiskin based?
Miiskin is headquartered in Copenhagen, Denmark, in the Europe region.
How does Miiskin make money?
Three revenue lines are on record. Consultation Fees are the primary driver. The others are compounded Prescription Fulfillment and bimatoprost/Latisse Prescription.
Who are Miiskin's main competitors?
Broad incumbents on record are Ro, Teladoc Health, Doctor On Demand and Hims & Hers Health. Direct peers are Curology, Skin + Me, First Derm, DirectDerm, Apostrophe and Dermatica.
Does Miiskin have an API?
Yes. Miiskin provides provider-facing software (Miiskin PRO) for healthcare practices including dermatology practices, primary care clinics, hospitals, and cancer centers to support clinical decision-making. The platform includes separate portals for patients and providers, enabling asynchronous consultations, photo-based evaluations, and treatment plan delivery. Specific API availability, endpoints, or developer documentation were not explicitly detailed in the source material.
What industry is Miiskin in?
Miiskin's product category is Teledermatology Services. Its primary akta.pro industry code is HLALAGAA, Dermatology Telemedicine Platforms, with a secondary code of HLALAIAK, Dermatology & Acne Prescribing + Pharmacy Delivery Platforms. Its NAICS code is 62111 and its SIC code is 8011.